Omeat, a cultivated meat startup, has completed the construction of a pilot facility with a capacity to produce 400 tons of product annually.
Situated outside Los Angeles, the 15,000 sq ft pilot facility houses bioreactors of up to 10,000 liters capacity. The company expects this plant to provide insights for scaling production and observing quality, taste, and safety standards.
Analyst QuickTake: Omeat is on a rapid growth trajectory, having only emerged from stealth a few months ago. The construction of this facility follows the development of its B2B arm for selling its ethical fetal bovine serum alternative, putting the company on track to becoming one of the quickest cell-cultured companies to begin revenue generation.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.